BioMarin Pharmaceutical Inc (BMRN.xnas)

BioMarin Pharmaceutical Inc (BMRN.xnas)

Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

BioMarin Pharmaceutical Inc (BMRN.xnas) Profile

BioMarin Pharmaceutical Inc (BMRN.xnas) is a world-leading biotechnology company headquartered in California, America. BioMarin operates in the United States, South America, Asia, and Europe with 34 offices locations in 20 countries and they will continue to expand into new markets and grow their team. BioMarin develops and commercialises first in class therapies for rare genetic diseases and it is a pioneer in treatments for debilitating and life-threatening conditions with business and research in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I) and the first to provide therapeutics for phenylketonuria (PKU). The company employes 3,000 people and has $1.7B (USD) in 2019 yearly revenue. BioMarin Pharmaceutical Inc stock (BMRN.xnas) is listed on NASDAQ and had a market capitalisation of $15.47B (USD) as of December 2021. The biotech sector has been in focus as of November 2021 due to the COVID-19 pandemic with drug approvals, with BioMarin being approved for Voxzogo injection. BioMarin plans to use the ongoing open-label extension studies to fulfil the post-marketing requirements of continued approval.

Holding cost
Trading hours in US Eastern Time

Start Trading BioMarin Pharmaceutical Inc (BMRN.xnas)
with a Market Leader Today

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

6 Reasons to Trade Share
CFDs with FP Markets

An Australian-regulated
forex & CFD broker

Go Long or Short

Increase your ability to profit in all market conditions Leverage options up to 20:1

Direct Market Access (DMA) Execution

Real-time, transparent share prices Control, Functionality and deep liquidity Full Market depth & see your orders in the queue

Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with superior client portal

24/5 Multilingual
Customer Support

Award winning support & personal account managers

Global Exposure

Low margins and competitive commission +10,000 products on global stocks across 4 continents

Earn Dividends

On long positions No ownership of physical shares necessary

Start Trading
in Minutes

Open an account now

bullet Access 10,000+ financial instruments
bullet Auto open & close positions
bullet News & economic calendar
bullet Technical indicators & charts
bullet Many more tools included

By supplying your email you agree to FP Markets privacy policy and receive future marketing materials from FP Markets. You can unsubscribe at any time.

Get instant Updates in Telegram
Sitemap | © FP Markets 2022